Understanding glucagon and GLP-1 influence in ALS is limited, and further studies are needed to investigate if dysregulated glucagon secretion contributes to abnormal glucose homeostasis and influences the disease progression. This evidence concerns the gene GLP1R and amyotrophic lateral sclerosis.